Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.20.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating activities:    
Net loss $ (2,534) $ (6,551)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 164 247
Provision for excess and obsolete inventories 23 19
Changes in allowance for doubtful accounts 0 55
(Gain) loss on revaluation of warrant liabilities (2,519) 1,122
Stock-based compensation expense 587 636
Amortization of debt discount and accretion of final payment fee 13 29
Common stock contribution to 401(k) plan 77 55
Loss on modification of warrants 0 257
Unrealized loss on foreign currency transactions 219 152
Changes in operating assets and liabilities:    
Accounts receivable 2,550 (188)
Inventories (55) (154)
Prepaid expenses, operating lease right-of-use assets, and other assets current and noncurrent (68) (142)
Accounts payable 96 (660)
Accrued and lease liabilities 37 (167)
Deferred revenues (312) 113
Net cash used in operating activities (1,722) (5,177)
Investing activities:    
Acquisition of property and equipment 0 (7)
Net cash used in investing activities 0 (7)
Financing activities:    
Proceeds from issuance of common stock and warrants, net 0 7,305
Principal payments on note payable (589) (591)
Proceeds from exercise of stock options 0 55
Net cash (used in) provided by financing activities (589) 6,769
Effect of exchange rate changes on cash (45) (4)
Net increase (decrease) in cash (2,356) 1,581
Cash at beginning of period 10,872 7,655
Cash at end of period 8,516 9,236
Supplemental disclosure of cash flow activities    
Cash paid for interest 32 96
Cash paid for income taxes 3 0
Supplemental disclosure of non-cash activities    
Initial recognition of operating lease right-of-use assets 0 1,454
Initial recognition of operating lease liabilities 0 1,498
Transfer of inventory to property and equipment 38 206
Share issuance for common stock contribution to 401(k) plan 155 191
Share issuance in lieu of cash compensation 50 0
Equipois sales earn-out $ 0 $ 22